Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010026 15k PGF2a cPLA2i 1.0 BCD110605C28 1.01 pmol/ml medium
LMFA03010026 15k PGF2a cPLA2i 1.0 BCD110605C30 1.12 pmol/ml medium
LMFA03010026 15k PGF2a cPLA2i 1.0 BCD110605C29 1.11 pmol/ml medium
LMFA03010026 15k PGF2a cPLA2i 20.0 BCD110605C64 0.729 pmol/ml medium
LMFA03010026 15k PGF2a cPLA2i 20.0 BCD110605C66 0.736 pmol/ml medium
LMFA03010026 15k PGF2a cPLA2i 20.0 BCD110605C65 0.576 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 1.0 BCD110605C16 1.14 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 1.0 BCD110605C17 1.15 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 1.0 BCD110605C18 1.11 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 20.0 BCD110605C54 0.938 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 20.0 BCD110605C52 1.01 pmol/ml medium
LMFA03010026 15k PGF2a PLDi 20.0 BCD110605C53 0.924 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 1.0 BCD110605C32 0.929 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 1.0 BCD110605C31 0.744 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 1.0 BCD110605C33 0.972 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 20.0 BCD110605C68 0.677 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 20.0 BCD110605C69 0.746 pmol/ml medium
LMFA03010026 15k PGF2a KDO+cPLA2i 20.0 BCD110605C67 0.727 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 1.0 BCD110605C19 1.27 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 1.0 BCD110605C20 1.11 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 1.0 BCD110605C21 1.28 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 20.0 BCD110605C56 1.05 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 20.0 BCD110605C57 0.82 pmol/ml medium
LMFA03010026 15k PGF2a KDO+PLDi 20.0 BCD110605C55 0.51 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C37 1.09 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C38 2.02 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C39 1.16 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C74 1.48 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C75 1.11 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C73 1.36 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 1.0 BCD110605C25 1.6 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 1.0 BCD110605C27 1.52 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 1.0 BCD110605C26 1.63 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 20.0 BCD110605C61 1.57 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 20.0 BCD110605C62 1.38 pmol/ml medium
LMFA03010026 15k PGF2a KDO+ATP+PLDi 20.0 BCD110605C63 2.32 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 1.0 BCD110605C15 1.51 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 1.0 BCD110605C14 1.98 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 1.0 BCD110605C13 1.83 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 20.0 BCD110605C49 1.65 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 20.0 BCD110605C50 1.68 pmol/ml medium
LMFA03010026 15k PGF2a KDO + ATP 20.0 BCD110605C51 1.56 pmol/ml medium
LMFA03010026 15k PGF2a KDO 1.0 BCD110605C08 2.41 pmol/ml medium
LMFA03010026 15k PGF2a KDO 1.0 BCD110605C07 1.44 pmol/ml medium
LMFA03010026 15k PGF2a KDO 1.0 BCD110605C09 1.11 pmol/ml medium
LMFA03010026 15k PGF2a KDO 20.0 BCD110605C45 0.721 pmol/ml medium
LMFA03010026 15k PGF2a KDO 20.0 BCD110605C44 0.642 pmol/ml medium
LMFA03010026 15k PGF2a KDO 20.0 BCD110605C43 0.75 pmol/ml medium
LMFA03010026 15k PGF2a C 0.0 BCD110605C03 1.88 pmol/ml medium
LMFA03010026 15k PGF2a C 0.0 BCD110605C01 1.11 pmol/ml medium